logo
'Mum's death days after cancer news not uncommon'

'Mum's death days after cancer news not uncommon'

Yahoo20-02-2025

A mother of three who died days after receiving a liver cancer diagnosis is a tragically common case, a charity has said.
Sian Ashcroft died last year aged 35 just 18 days after she was diagnosed with cholangiocarcinoma (CCA), a form of liver cancer.
Also known as bile duct cancer, CCA has a "dismal" five-year survival rate of between 2-9% compared to the England average for all cancers which is 54%, CCA charity AMMF said.
The charity said this was because patients were often diagnosed at a late stage and medical teams were unaware of the treatments available, with more than 50% of CCA patients receiving no cancer-specific treatment at all.
The Royal College of General Practitioners said that diagnosing some cancers in primary care could be incredibly challenging but that the proportion of cancers diagnosed after referral by a GP had increased in latest figures.
The Department of Health and Social Care has been contacted for comment.
Ms Ashcroft, from Ormskirk, first started to realise that something was wrong with her health when she tried to donate blood in the spring of 2023 and was told she was anaemic, her family said.
She began taking iron tablets to address her anaemia but, by the August, she started to experience abdominal pain, which she initially put down to food poisoning.
When the pain continued, her GP referred her for hospital tests. At first, she was told she probably had gallstones but, as the pain worsened, she was admitted to hospital for surgery to insert a stent in her bile duct.
In early November 2023, at a follow-up appointment, Sian was told that she had a 2cm (0.79in) lesion on her liver and several smaller lesions that were concerning. Although chemotherapy was discussed, Ms Ashcroft did not receive a CCA diagnosis for another two months.
In January 2024, she was diagnosed with terminal cholangiocarcinoma at Aintree University Hospital and told she had months to live. She died 18 days later.
"Sian's prognosis was an incredible shock for everyone," her mum, Sue Dowling said.
"She had become increasingly poorly, with frequent visits to her GP and time spent in hospital, but her diagnosis came too late to save her.
"Despite this, she remained incredibly positive, she never lost her sense of humour, she was exceptionally brave and, above all, she never stopped thinking about her family."
AMMF chief executive, Helen Morement, said Ms Ashcroft's story was, "tragically", not uncommon.
She said the majority of CCA diagnoses were late-stage and only about 21% were diagnosed at stage one or two, which was well below the proportion for all cancers generally (54%).
"Often, patients don't fit the profile of what many assume a liver cancer patient should look like," Ms Morement said.
"Unlike the other more well-known type of primary liver cancer – Hepatocellular carcinoma (HCC) - there isn't an established link to liver cirrhosis, viral hepatitis, alcohol or other lifestyle factors."
New evidence suggests cases are rising significantly, the charity says. Figures published by the NHS recorded the number of cases of CCA in 2020 in England as 2,706, almost the same as HCC (2,792).
The charity said this should be a significant cause for concern, given that the prognosis for CCA is "currently so dismal".
There are a number of treatments that can help to control symptoms and delay progression of the cancer, however more than 50% of CCA patients are not given any cancer-specific treatment at all, according to research commissioned by AMMF.
"People are dying because there is a lack of knowledge of what is available," Ms Morement said.
"If they are diagnosed somewhere where they do not have a lot of experience the patient needs to be referred to someone who is an expert because time is of the essence."
On Thursday, as part of World Cholangiocarcinoma Day, Liverpool's Royal Liver Building is set to turn purple to raise awareness for AMMF's Rethink Liver Cancer campaign and in memory of Sian Ashcroft
As part of the campaign, the charity is calling on clinicians, health planners and policy makers to "rethink" the disease, to help ensure that people with CCA receive the best possible chance of improving the health outcomes.
"If someone comes to a doctor with these unusual symptoms and they're not clearing up they should run a liver test, which will pick up if there is something wrong," Ms Morement said.
"We really need to get earlier diagnoses and to do that we need GPs to be more aware."
The Royal College of General Practitioners said "due to the intense workload and workforce pressures on our service", GPs often lacked the time with patients to have the conversations needed to consider less likely diagnoses.
"The government urgently needs to invest in primary care and support our workforce with recruitment and retention initiatives," Professor Kamila Hawthorne, chair of the Royal College of GPs, said.
"Diagnosing some cancers in primary care can be incredibly challenging as early symptoms may often be vague or indicative of more common and less serious conditions - and some cancers, such as this one, may not present clinically until they are already at quite a late stage.
"However, the proportion of cancers diagnosed after referral by a GP increased to 60% by 2020, according to latest figures."
Listen to the best of BBC Radio Merseyside on BBC Sounds and follow BBC Merseyside on Facebook, X and Instagram and watch BBC North West Tonight on BBC iPlayer.
AMMF
Cancer Research
Department of Health and Social Care
NHS - Cholangiocarcinoma

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Clinique Laflamme Wins the 2025 Consumer Choice Award
Clinique Laflamme Wins the 2025 Consumer Choice Award

Indianapolis Star

time6 days ago

  • Indianapolis Star

Clinique Laflamme Wins the 2025 Consumer Choice Award

MONTRÉAL, QC / ACCESS Newswire The Consumer Choice Award (CCA) is proud to name Clinique Laflamme as the top medical aesthetic clinic in the Greater Montreal area. This prestigious recognition highlights the excellence of an establishment at the intersection of science, cutting-edge technology, and the art of personalized beauty. Since its founding in 2010, Clinique Laflamme has established itself as a leading authority in medical aesthetics in Quebec. Its mission is clear: to place medicine at the service of natural, lasting beauty, while respecting overall well-being, through a personalized approach and the integration of next-generation technologies. At the heart of this vision is Dr. Nathalie Laflamme, a physician recognized in aesthetic medicine by the Collège des médecins du Québec. Certified by the European College of Aesthetic Medicine & Surgery (ECAMS), she is a leading expert in advanced aesthetic injectables and tissue biostimulation, offering holistic and harmonious rejuvenation with natural results and customized care. Creator of the exclusive Lift Laflamme© protocol, she embodies a new generation of aesthetic physicians combining technical mastery with artistic vision. Driven by a constant desire to refine her practice, Dr. Laflamme has expanded her expertise through advanced training in Europe, the United States, and Canada. This ongoing commitment to education allows her to remain at the forefront of the most effective, innovative, and safest medical advancements in the field. Clinique Laflamme offers a full range of high-end medical-aesthetic treatments, including: Next generation injectables: neuromodulators and tailored fillers to smooth wrinkles, sculpt volume, and enhance features with finesse. Laser and light-based technologies: for pigmentation correction, skin tightening, collagen stimulation, and precision hair removal. Non-invasive body contouring: advanced technology solutions designed to sculpt the body without surgery or downtime. Medical-grade skincare: personalized treatments that promote luminous, even, and resilient skin. Tissue biostimulation: a revolutionary breakthrough that reactivates the skin's natural regenerative power, from face to body, for a tightening effect and deep revitalization – all without invasive procedures. 'This award reflects our commitment to delivering ethical, science-based, and personalized aesthetic care. We believe in an evolving beauty – one that is supported by medical intelligence, technological precision, and a deep understanding of our patients,' says Dr. Laflamme. 'We are deeply grateful to our patients for their continued trust. It is an honour we carry with pride and responsibility.' Guided by a culture of excellence, Clinique Laflamme stands as a leader in modern aesthetic medicine. Visionary, refined, and deeply human, it remains the destination of choice for those seeking personalized care, elegant results, and a safe, cutting-edge approach to beauty and well-being. To learn more about Clinique Laflamme, CLICK HERE or visit About Consumer Choice Award: Consumer Choice Award has been recognizing and promoting business excellence in North America since 1987. Its rigorous selection process ensures that only the most outstanding service providers in each category earn this prestigious recognition. Visit to learn more. Contact Information: Sumi Saleh Communications Manager ssaleh@ SOURCE: Consumer Choice Award View the original press release on ACCESS Newswire

NHS doubles amount its spending on private companies
NHS doubles amount its spending on private companies

Yahoo

time11-06-2025

  • Yahoo

NHS doubles amount its spending on private companies

NHS trusts in the South West have almost doubled the amount they are spending on private companies over the past three years. A Freedom of Information (FOI) request submitted by the GMB Union showed NHS trusts across the region pay at least £151m a year to private companies. The total annual spend has almost doubled since 2021/2022. Figures also reveal that almost £64m has been spent on private ambulances in the region over the same time period. Speaking for GMB members, Mo Akbar has "demanded" an end to privatisation. A Department of Health and Social Care spokesperson said they remain committed to working with the independent sector to "slash elective waiting lists and give patients more choice". The outsourcing of NHS services threatens the financial viability and sustainability of the health service, union members claim. This is because the independent sector providers are not obligated to train staff, which can undermine the quality and scope of training for doctors and other healthcare professionals, union members added. Mr Akbar, an ambulance worker, argues it symbolises a decline in the quality of care for NHS patients, as private providers may prioritise profits over health. "Workers and communities should have more say in how the NHS is run, ensuring decisions focus on patient care, not financial targets," he said. "Health outcomes are tied to poverty, housing, and working conditions, so NHS rebuilding must also address these inequalities. "We demand real terms restorative pay from the 14 years of brutal austerity. "This Labour government will have a crisis of legitimacy if they choose a path of further privatisation of the NHS, which would put at risk the sense of the collectivism that is at the heart of our health service." He added that only 11 South West trusts responded to the FOI - meaning the true figure being paid to the private sector could be far higher than £151m. A Department of Health and Social Care spokesperson said: "Through our Plan for Change, we are making good progress having already cut the waiting list by 200,000 since this government took office and delivered 3.6 million extra appointments." Follow BBC Bristol on Facebook, X and Instagram. Send your story ideas to us on email or via WhatsApp on 0800 313 4630. Hospital jobs to be outsourced from NHS Job losses as urgent NHS call firm collapses NHS cuts will have 'profound effect' on patients Nearly half of NHS workers looking to move jobs NHS England- South West

CareSource announces John Koehn as Massachusetts market president following its recent affiliation with Commonwealth Care Alliance
CareSource announces John Koehn as Massachusetts market president following its recent affiliation with Commonwealth Care Alliance

Yahoo

time09-06-2025

  • Yahoo

CareSource announces John Koehn as Massachusetts market president following its recent affiliation with Commonwealth Care Alliance

John Koehn DAYTON, Ohio and BOSTON, June 09, 2025 (GLOBE NEWSWIRE) -- CareSource, a nationally recognized nonprofit managed care organization, announced the appointment of John Koehn as the Massachusetts market president, effective today. This announcement follows CareSource's recent affiliation with Commonwealth Care Alliance (CCA), a nonprofit organization committed to providing innovative health plans and care delivery programs for individuals with significant health needs. Koehn brings extensive and proven health care experience in integrated Long-Term Services and Supports (LTSS) to his role at CCA. His prior experience includes serving as market president for AmeriHealth Caritas's LTSS program in Pennsylvania, where, under his leadership, the organization saw its first profitable year which enabled reinvestments in members and communities. Additionally, as health plan president at Amerigroup New Jersey, Koehn implemented strategies that helped the organization achieve the highest quality scores in the state. Most recently, he served as senior vice president of external affairs at InnovAge, where he led government relations efforts at both state and federal levels. "John's health care and leadership expertise are exactly what we need to ensure residents of Massachusetts with complex health needs continue to have access to person-centered, high-quality health care," said Erhardt Preitauer, CEO of CareSource. "His commitment to operational excellence and the member and caregiver experience will help to ensure CCA's long-term sustainability and strong commitment to our members, patients and the Commonwealth.' CareSource, through its affiliation with CCA, serves nearly 50,000 Massachusetts residents, many of whom face significant health challenges and social barriers. The organization also provides specialized primary care and innovative clinical programs, including a respite care unit for individuals experiencing acute behavioral health crises. In his new role, Koehn will work closely with CareSource leadership and the executive team of CCA to ensure a seamless integration of services and operations to bolster the services and supports available to individuals with complex health needs in Massachusetts. "Joining CareSource at this pivotal time is an honor," said Koehn. "I look forward to working alongside our talented CCA team to strengthen partnerships and ensure that everyone in Massachusetts has access to coordinated care that can genuinely enhance their quality of life.' Koehn holds a Master of Arts degree in History from the University of Michigan and a Bachelor of Arts degree in History from the University of Connecticut. He will be based in Massachusetts as he steps into his new role. About CareSourceCareSource is a nonprofit, nationally recognized managed care organization with over two million members. CareSource administers one of the largest Medicaid managed care plans in the U.S. The organization offers health insurance, including Medicaid, Health Insurance Marketplace and Medicare products. As a mission-driven organization, CareSource is transforming health care with innovative programs that address the social determinants of health, prevention and access to care. For more information, visit us at or follow us on X, formerly known as Twitter, LinkedIn or Facebook. About Commonwealth Care Alliance Commonwealth Care Alliance® (CCA) is a mission-driven healthcare services organization that offers innovative health plans and care delivery programs designed for individuals with the most significant needs. Through our flagship Senior Care Options (SCO) and One Care plans in Massachusetts, CCA delivers comprehensive, integrated, and person-centered care by coordinating the services of local staff, provider partners, and community-based organizations to meet the unique needs of each individual we serve. Attachment John Koehn CONTACT: Vicki McDonald CareSource 216.502.6395 Sarah Magazine Commonwealth Care Alliance 617.470.6755 mediainquiries@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store